2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | - | - | 62.308 | 60.219 | 467.456 | 499.979 |
Total Income - EUR | - | - | - | - | - | - | 62.308 | 60.219 | 467.494 | 509.924 |
Total Expenses - EUR | - | - | - | - | - | - | 2.794 | 18.710 | 176.332 | 230.479 |
Gross Profit/Loss - EUR | - | - | - | - | - | - | 59.514 | 41.508 | 291.163 | 279.446 |
Net Profit/Loss - EUR | - | - | - | - | - | - | 59.012 | 41.047 | 287.639 | 275.944 |
Employees | - | - | - | - | - | - | 0 | 1 | 3 | 2 |
Check the financial reports for the company - Mazilu Chirurgie Reconstructivă S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 198.952 | 143.813 | 2.135 | 3.062 | - | - | - | - | - | - |
Current Assets | - | - | - | - | - | - | 57.599 | 42.426 | 165.033 | 329.820 |
Inventories | - | - | - | - | - | - | 0 | 11.824 | 21.331 | 89.390 |
Receivables | - | - | - | - | - | - | 0 | 0 | 137.782 | 20.455 |
Cash | - | - | - | - | - | - | 57.599 | 30.601 | 5.920 | 219.975 |
Shareholders Funds | - | - | - | - | - | - | 59.054 | 41.095 | 287.688 | 423.258 |
Social Capital | - | - | - | - | - | - | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | - | - | 1.607 | 3.465 | 21.276 | 105.514 |
Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year | 8622 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.